Financial Performance - For the three months ended March 31, 2023, the company reported a net income of $1,706,425, driven by interest income of $2,758,504, offset by operating expenses of $495,083 and income tax expenses of $556,996[117]. - The company has no operating revenues to date and does not expect to generate any until after completing its initial business combination[116]. - Net income (loss) per share is calculated by dividing net income (loss) by the weighted average number of common stock outstanding, with no Public or Private Placement Warrants exercised as of March 31, 2023[138]. Investments and Financing - The company had investments held in the Trust Account amounting to $262,396,797 as of March 31, 2023, which are intended to be used for completing a business combination[124]. - The initial public offering generated gross proceeds of $250,000,000 from the sale of 25,000,000 units, with each unit priced at $10.00[119]. - The company incurred offering costs of $14,420,146 for its initial public offering, which included $5,000,000 in underwriting fees[121]. - The company may need to obtain additional financing to complete its business combination or if a significant number of public shares are redeemed[128]. Business Combination and Future Plans - The company intends to hold a special meeting on June 12, 2023, to vote on extending the deadline for completing its initial business combination from June 14, 2023, to January 14, 2024[115]. - The company expects to incur significant costs related to being a public company and for due diligence expenses in connection with searching for a business combination[116]. Company Structure and Compliance - The company has no long-term debt or off-balance sheet arrangements as of March 31, 2023[130]. - The company qualifies as an "emerging growth company" under the JOBS Act, allowing it to delay the adoption of new accounting standards[133]. - The company is evaluating the benefits of reduced reporting requirements under the JOBS Act, which may exempt it from certain disclosures for five years post-IPO[135]. - Common stock subject to possible redemption is classified as temporary equity, affecting the presentation on the balance sheet[137]. - The company accounts for warrants based on specific terms, determining whether they are equity or liability classified instruments[140].

Compensation and Governance - The compensation committee is responsible for reviewing and approving the CEO's compensation based on annual corporate goals and objectives [339]. - The compensation committee may retain independent advisers and is responsible for their appointment and oversight [341]. - The company has agreed to pay its Sponsor $10,000 per month for up to 18 months for office space and administrative support [340]. Director Nomination and Qualifications - The nominating and corporate governance committee assists the board in identifying and recommending candidates for director nominations [342]. - The company has not established specific minimum qualifications for director candidates but considers various factors such as integrity and professional reputation [344]. Business Conduct and Ethics - The Code of Business Conduct and Ethics applies to all directors, officers, and employees, and amendments will be disclosed on the company's website [345]. - Officers and directors are required to present business opportunities to the corporation if they are within its line of business and financially feasible [346]. Business Combinations and Valuation - The company will obtain an independent valuation opinion if pursuing a business combination with an affiliated entity [350]. Indemnification and Insurance - The Amended and Restated Certificate of Incorporation provides indemnification for officers and directors to the fullest extent allowed by Delaware law [353]. - The company has purchased directors' and officers' liability insurance to cover defense costs and indemnification obligations [354].

Financial Performance - As of September 30, 2022, the company reported a net income of $580,455, driven by interest income of $1,156,843 from investments in the Trust Account, after accounting for operating expenses of $343,952 and income tax expenses of $232,436[110]. - For the nine months ended September 30, 2022, the company achieved a net income of $219,201, with total interest income of $1,528,774, offset by operating expenses of $1,034,137 and income tax expenses of $275,436[110]. IPO and Fundraising - The company completed its IPO on December 14, 2021, raising gross proceeds of $250 million from the sale of 25 million units at $10.00 per unit[113]. - An additional $3,750,000 was raised from the partial exercise of the underwriter's over-allotment option, bringing total gross proceeds to $256,287,500, which was placed in a Trust Account[114][115]. Cash and Working Capital - As of September 30, 2022, the company had $516,408 in cash available for working capital purposes, with $1,010,056 used in operating activities during the nine months[116]. - The company has no long-term debt or off-balance sheet arrangements as of September 30, 2022, and does not anticipate needing to raise additional funds for operating expenditures[121][119]. Business Combination - The company is assessing the feasibility of completing a Business Combination before the mandatory liquidation date of June 14, 2023, but there is no assurance that this will be achieved[120]. - The company intends to use substantially all funds in the Trust Account to complete its Business Combination and may utilize remaining proceeds for working capital and growth strategies[116]. Warrants and Obligations - The company has issued 13,164,375 Public and Private Placement Warrants, which are contingently exercisable and excluded from diluted earnings per share calculations as of September 30, 2022[128]. - The company has no obligations related to off-balance sheet financing arrangements or special purpose entities[121].

Financial Performance - As of June 30, 2022, the company reported a net loss of $19,795 for the three months and a net loss of $361,254 for the six months, primarily due to operating expenses and interest income [102]. - As of June 30, 2022, the company had $722,297 in cash available for working capital purposes [107]. - The company has no long-term debt or off-balance sheet arrangements as of June 30, 2022 [112][113]. IPO and Fundraising - The company completed its IPO on December 14, 2021, raising gross proceeds of $250 million from the sale of 25 million units at $10.00 per unit [104]. - An additional $3.75 million was generated from the partial exercise of the underwriter's over-allotment option, bringing total gross proceeds to $253.75 million [105]. - The company placed $256,287,500 of net proceeds from the IPO into a trust account, invested in U.S. government securities [106]. - The company may need to raise additional funds to complete a Business Combination or to cover redemptions of Public Shares [110]. Going Concern - Management has expressed substantial doubt about the company's ability to continue as a going concern if a Business Combination is not completed by June 14, 2023 [111]. Warrants and Growth Status - The company has issued 13,164,375 warrants to purchase Class A common stock at $11.50 per share, which have not yet been exercised [119]. - The company qualifies as an "emerging growth company" under the JOBS Act, allowing it to delay the adoption of new accounting standards [114].

Financial Performance - As of March 31, 2022, the company reported a net loss of $341,459, which consisted of operating expenses and interest income from investments held in the Trust Account[111]. - For the three months ended March 31, 2022, the company used $713,340 in cash for operating activities[116]. - As of March 31, 2022, the company had $813,124 in cash available for working capital purposes[116]. - The company has no long-term debt or off-balance sheet arrangements as of March 31, 2022[120]. IPO and Fundraising - The company completed its IPO on December 14, 2021, raising gross proceeds of $250 million from the sale of 25,000,000 units at $10.00 per unit[112]. - An additional $9.5 million was raised from the sale of 950,000 private placement units at the same price during the IPO[114]. - Following the IPO and the partial exercise of the over-allotment option, the company placed $256,287,500 in a Trust Account, invested in U.S. government securities[115]. - The underwriters are entitled to deferred underwriting commissions of $8,956,250, payable only if a Business Combination is completed[121]. Warrants and Growth Status - The company has issued 13,164,375 warrants to purchase Class A common stock at $11.50 per share, which are contingently exercisable[127]. - The company qualifies as an "emerging growth company" under the JOBS Act, allowing it to delay the adoption of new accounting standards[122].

Financial Performance - The company had a net loss of $118,735 for the year ended December 31, 2021, primarily due to operating expenses of $65,270 and Delaware franchise taxes of $67,995, offset by interest income of $823[292]. - The company incurred a net loss of $118,735 for the period from May 20, 2021, to December 31, 2021, resulting in a basic and diluted net loss per share of $(0.01) for both Class A and Class B common stock[331]. - The company’s accumulated deficit as of December 31, 2021, was $(7,514,864)[327]. - The total net loss allocation was $(22,921) for Class A and $(95,813) for Class B common stock[383]. - The total income tax benefit for the year ended December 31, 2021, was $14,106, which included a deferred expense of $27,813[371]. Initial Public Offering (IPO) - The initial public offering (IPO) generated gross proceeds of $250,000,000 from the sale of 25,000,000 units, with each unit priced at $10.00[294]. - The company raised an additional $3,750,000 from the over-allotment option exercised by underwriters[344]. - Offering costs for the IPO amounted to $14,213,896, including $5,000,000 in underwriting fees and $8,956,250 in deferred underwriting fees[365]. - The Company sold 25,375,000 Units at a price of $10.00 per Unit during the IPO, generating gross proceeds of $253,750,000[386]. Cash and Investments - As of December 31, 2021, the company had investments held in the Trust Account amounting to $256,288,315, which will be used to complete the initial business combination[297]. - Cash used in operating activities for the year ended December 31, 2021, was $34,640, while net cash provided by financing activities was $257,848,604[296]. - The company has cash of $1,526,464 outside the Trust Account, intended for identifying and evaluating target businesses[298]. - The company had cash and cash equivalents of $1,526,464 at the end of the period[338]. - As of December 31, 2021, the assets held in the Trust Account were valued at $256,288,315 in U.S. Treasury Securities[408]. Liabilities and Obligations - As of December 31, 2021, the company reported total liabilities of $9,661,595, which includes a deferred underwriting fee payable of $8,956,250[325]. - The company has no long-term debt, capital lease obligations, or long-term liabilities as of December 31, 2021[310]. - The total deferred underwriting fee is $8,956,250, which will be payable only if the Company completes a Business Combination[394]. - The company may need to seek additional financing if the cash portion of the purchase price for a business combination exceeds the available funds in the Trust Account[303]. Business Operations - The company has not commenced any operations and will not generate operating revenues until after completing a business combination[342]. - The company has agreed to pay its Sponsor $10,000 per month for office space and administrative services[305]. - The company expects to incur approximately $400,000 for legal, accounting, and due diligence expenses related to business combinations[301]. - The Company completed its IPO, which alleviated prior liquidity concerns, allowing it to sustain operations for at least one year from the financial statement issuance date[358]. Stock and Warrants - The common stock subject to possible redemption is valued at $10.10 per share, totaling $256,287,500 for 25,375,000 shares[326]. - The Company issued 12,687,500 Public Warrants and 953,750 Private Placement Warrants as of December 31, 2021[399]. - The Company has the option to issue up to 1,000,000 shares of preferred stock, but none were issued as of the reporting date[396]. - The Company has determined that its warrant agreements qualify for equity accounting treatment[383]. - Warrants may be redeemed at a price of $0.01 per Warrant if the last sale price of common stock equals or exceeds $18.00 per share for any 20 trading days within a 30-trading day period[402]. Compliance and Accounting - The financial statements were audited and presented fairly in all material respects, in conformity with GAAP[320]. - The Company is classified as an emerging growth company, allowing it to defer compliance with new or revised financial accounting standards[360]. - The Company has established a full valuation allowance of $13,707 against deferred tax assets due to uncertainty regarding future realization[375]. - The Company has determined there were no subsequent events requiring adjustment or disclosure after the balance sheet date[409].

Financial Performance - As of September 30, 2021, the company had a net loss of $1,160, primarily due to general and administrative expenses[81]. - The company had no cash used in operating activities from inception through September 30, 2021[85]. - There were no outstanding Working Capital Loans as of September 30, 2021, and the company does not anticipate needing additional funds for operating expenditures[86]. - The company has no long-term debt or off-balance sheet arrangements as of September 30, 2021[89]. IPO and Fundraising - The company completed its IPO on December 14, 2021, raising gross proceeds of $250 million from the sale of 25,000,000 units at $10.00 per unit[82]. - An additional $3.75 million was raised from the sale of 375,000 over-allotment units, bringing total gross proceeds to $253.75 million[83]. - The net proceeds of $256,287,500 from the IPO and private placements were placed in a trust account, to be invested in U.S. government securities[84]. - The underwriters are entitled to a deferred underwriting commission of $8,956,250, payable only if a Business Combination is completed[90]. Regulatory and Risk Factors - The company qualifies as an "emerging growth company" under the JOBS Act, allowing it to delay the adoption of new accounting standards[91]. - As of September 30, 2021, the company was not subject to any market or interest rate risk, with investments held in short-term U.S. government securities[99].